BUY Redington Limited — Chandan Taparia, Motilal Oswal
Redington share price target & all analyst calls
byChandan Taparia, Motilal OswalHorizon: NA (inferred Intraday)5 Oct 2026, 9:27 am ISTvia CNBC Awaaz.
Entry₹409.25Inferred
Stop loss₹398-2.75% risk
At expiry₹412.55 Oct 2026, 3:20 pm
Expired+0.79%
Follow Chandan Taparia for new calls(14% target hit, 65 closed calls)Get alertsWatch REDINGTON for new buy/sell callsGet alerts
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 supporting0 opposing
Neutral / worth noting (0)
Nothing found in this tip’s window yet.
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Redington
- BUY — Amit Seth29 Sept 2026 · ~2 weeks · target ₹425 · SL hit
- BUY — Siddharth Rai Mangala23 Sept 2026 · ~2 weeks · target ₹425 · SL hit
- BUY — Amit Gupta22 Sept 2026 · ~2 weeks · target ₹430 · SL hit
- BUY — IDBI Capital22 Sept 2026 · ~3 months · target ₹449 · Active
- BUY — Chandan Taparia, Motilal Oswal18 Sept 2026 · Same day · target ₹421 · Expired
More from Chandan Taparia, Motilal Oswal
- BUY Titan Company5 Oct 2026 · ~3 months · target ₹4,750 · Active
- BUY LLOYDS ENGINEERING WORKS5 Oct 2026 · ~2 weeks · target ₹107 · Active
- BUY Coforge5 Oct 2026 · Same day · target ₹1,880 · SL hit
- BUY Laurus Labs2 Oct 2026 · ~3 months · target ₹2,100 · Active
- BUY Shilpa Medicare1 Oct 2026 · ~3 months · target ₹1,220 · Active

